- Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan
- Bavarian Nordic konverterer eksisterende kreditfacilitet til bæredygtighedsrelateret lån
- Bavarian Nordic tilslutter sig globalt initiativ i kampen mod mpox i Afrika
- Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa
- Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to EMA
- Bavarian Nordic indsender registreringsansøgning for chikungunyavaccine til de europæiske sundhedsmyndigheder
- Bavarian Nordic indsender registreringsansøgning for chikungunya-vaccine til de amerikanske sundhedsmyndigheder
- Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate
- Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine
- Bavarian Nordic indsender supplerende ansøgning til de amerikanske sundhedsmyndigheder om godkendelse af frysetørret koppe- og mpoxvaccine
More ▼
Key statistics
On Tuesday, Bavarian Nordic A/S (0DPB:LSE) closed at 176.30, -8.34% below its 52-week high of 192.35, set on Jul 17, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 176.30 |
---|---|
High | 176.30 |
Low | 176.30 |
Bid | 179.10 |
Offer | 188.25 |
Previous close | 176.50 |
Average volume | 9.93k |
---|---|
Shares outstanding | 78.12m |
Free float | 78.05m |
P/E (TTM) | 13.71 |
Market cap | 13.77bn DKK |
EPS (TTM) | 12.86 DKK |
Data delayed at least 20 minutes, as of Jul 16 2024 17:36 BST.
More ▼